LILRB1 Is a Prognostic‐Related Biomarker Correlated With Immune Infiltration in Head–Neck Squamous Cell Carcinoma
Cancer Medicine · 2026-03 · 15 (3)
DOI: 10.1002/cam4.71727 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, online erschienen am 25.03.2026. Verfasst von Shuai Chen und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, the First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen…. Hauptthemen laut MEDLINE: Leukocyte Immunoglobulin-like Receptor B1, Biomarkers, Tumor, Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Fujian Province, Natural Science Basic Research Program of Xiamen City, Xiamen Medical and Health Guiding Project.
Abstract (Originalsprache)
Background
Conventional treatment strategies and immunotherapy yield low response rates in head and neck squamous cell carcinoma (HNSCC). This study aimed to explore the potential of immunosuppressive receptor leukocyte immunoglobulin‐like receptor subfamily B member 1 (LILRB1) for developing effective immunotherapies for HNSCC.
Methods
Clinical data collection and analysis were determined using Tumor Immunity Estimation Resource Database (TIMER) and Cancer Treatment Response gene signature DataBase (CTR‐DB). Immunohistochemistry was used to detect protein level in fresh breast cancer tissues. RNA sequencing was employed to screen the downstream signaling pathway in WBP2‐overexpressed cells. Tumor xenograft model and Flow Cytometry were performed to monitor tumor growth and cell apoptosis, respectively.
Results
In this study, high expression of LILRB1 in HNSCC tissues was observed compared to normal tissues. HNSCC patients with high LILRB1 expression exhibited a better prognosis, which was influenced by tumor mutation burden. Functional network analysis revealed a positive association between LILRB1 and chemokine signaling pathways. Copy number variation of LILRB1 was positively correlated with the infiltration of CD8+ T cells and M1 macrophages. The prognostic effect of LILRB1 depends on CD8+ T‐cell abundance, especially in HNSCC with a low neoantigen load. High LILRB1 expression was associated with a higher immune score, indicating favorable outcomes in HNSCC patients receiving immunotherapy. Notably, LILRB1 was specifically expressed in SPP1‐ACP5+ macrophages; in these cells, high LILRB1 might reduce the proportion of cancer cells via the SPP1‐CD44 axis, and subsequently regulate CD8+ T cell enrichment through the C‐X‐C motif chemokine 13 (CXCL13)‐CXCR5 axis.
Conclusion
Collectively, high LILRB1 expression in HNSCC was accompanied by the infiltration of various immune effector cells. LILRB1 may shape the tumor microenvironment of HNSCC, mediating the interactions between cancer cells and macrophages, as well as between cancer cells and CD8+ T cells, via the SPP1‐CD44 and CXCL13‐CXCR5 axes. Our findings illustrate that LILRB1 serves as a prognostic‐related biomarker associated with immune infiltration in HNSCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otolaryngology-Head and Neck Surgery, the First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, People's Republic of China.
- Xiamen Key Laboratory of Otolaryngology Head and Neck Surgery, Xiamen, China.
- Department of Scientific Research, the First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, People's Republic of China.
- The Third Clinical Medical College, Fujian Medical University, Xiamen, Fujian, People's Republic of China.
- Shenyang City University, Shenyang City, China.
- Medical Oncology, the First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, People's Republic of China.
ORCID-Profile: Shuai Chen, Xianyang Luo
Förderung
- Natural Science Foundation of Fujian Province
- Natural Science Basic Research Program of Xiamen City
- Xiamen Medical and Health Guiding Project
- Science Foundation of the Fujian Provincial Commission of Health and Family Planning
Zitieren
APA
Chen, S., Wu, Q., Gu, S., Zhou, Y., Cai, M., Wu, J., He, J., He, J., Lin, J., Hong, Z., Zhang, B., & Luo, X. (2026). LILRB1 Is a Prognostic‐Related Biomarker Correlated With Immune Infiltration in Head–Neck Squamous Cell Carcinoma. Cancer Medicine, 15(3). https://doi.org/10.1002/cam4.71727
Vancouver
Chen S, Wu Q, Gu S, Zhou Y, Cai M, Wu J, et al. LILRB1 Is a Prognostic‐Related Biomarker Correlated With Immune Infiltration in Head–Neck Squamous Cell Carcinoma. Cancer Medicine. 2026;15(3). doi:10.1002/cam4.71727
BibTeX
@article{Chen2026,
author = {Chen, Shuai and Wu, Qiuwan and Gu, Shuo and Zhou, Yi and Cai, Mingquan and Wu, Junhua and He, Jing and He, Jingjing and Lin, Juli and Hong, Zhicong and Zhang, Binghuang and Luo, Xianyang},
title = {LILRB1 Is a Prognostic‐Related Biomarker Correlated With Immune Infiltration in Head–Neck Squamous Cell Carcinoma},
journal = {Cancer Medicine},
year = {2026},
volume = {15},
number = {3},
doi = {10.1002/cam4.71727}
}
EUVIMED